Brain SPECT study of common ground between hypothyroidism and depression

International Journal of Neuropsychopharmacology

Volumn 10, Issue 1, 2007, Pages 99-106

  Krausz, Yodphat ^a   Freedman, Nanette ^a   Lester, Hava ^a   Barkai, Gavriel ^b   Levin, Tomer ^c   Bocher, Moshe ^a   Chisin, Roland ^a   Lerer, Bernard ^a   Bonne, Omer ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

99mTc HMPAO SPECT; Depression; Hypothyroidism; rCBF

Indexed keywords

ALPRAZOLAM; BROTIZOLAM; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; THYROXINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; HYPOTHYROIDISM; MAJOR DEPRESSION; MALE; OCCIPITAL LOBE; PARIETAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BRAIN; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PILOT PROJECTS; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; TECHNETIUM TC 99M EXAMETAZIME; THYROXINE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 33846286081     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145706006481     Document Type: Article

References (33)

1. Acton PD, Friston KJ (1998). Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies. European Journal of Nuclear Medicine 25, 663-667.
2. Aronson R, Offman HJ, Joffe RT, Naylor CD (1996). Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Archives of General Psychiatry 53, 842-848.
3. Bauer M, Heinz A, Whybrow PC (2002). Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Molecular Psychiatry 7, 140-156.
4. Brody AL, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, Phelps ME, Huang SC, Wu HM, Ho ML, et al. (2001). Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Archives of General Psychiatry 58, 631-640.
5. Catani M, Jones DK, Donato R, Ffytche DH (2003). Occipito-temporal connections in the human brain. Brain 126, 2093-2107.
6. Constant EL, de Volder AG, Ivanoiu A, Bol A, Labar D, Seghers A, Cosnard G, Melin J, Daumerie C (2001). Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study. Journal of Clinical Endocrinology and Metabolism 86, 3864-3870.
7. Davis JD, Stern RA, Flashman LA (2003). Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: significance in the elderly. Current Psychiatry Reports 5, 384-390.
8. Drevets WC (2000). Neuroimaging studies of mood disorders. Biological Psychiatry 48, 813-829.
9. Folstein MF, Folstein SE, McHugh PR (1975). 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189-198.
10. Guedj E, Taieb D, De Laforte C, Ceccaldi M, Mundler O (2005). Similitude of brain perfusion pattern in hypothyroidism and early Alzheimer's disease: physiopathologic considerations. Journal of Nuclear Medicine 46, 1247; author reply 1247-1248.
11. Hamilton M (1960). A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 23, 56-62.
12. Jackson IM (1998). The thyroid axis and depression. Thyroid 8, 951-956.
13. Jorge R, Robinson RG (2002). Mood disorders following traumatic brain injury. NeuroRehabilitation 17, 311-324.
14. Krausz Y, Freedman N, Lester H, Newman JP, Barkai G, Bocher M, Chisin R, Bonne O (2004). Regional cerebral blood flow in patients with mild hypothyroidism. Journal of Nuclear Medicine 45, 1712-1715.
15. Marangell LB (2002). Thyroid hormones and mood: are population data applicable to clinical cohorts? Acta Psychiatrica Scandinavica 106, 1-2.
16. Marangell LB, George MS, Callahan AM, Ketter TA, Pazzaglia PJ, L'Herrou TA, Leverich GS, Post RM (1997). Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. Archives of General Psychiatry 54, 214-222.
17. Mayberg HS (2003). Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin 65, 193-207.
18. Moroney JT, Bagiella E, Desmond DW, Hachinski VC, Molsa PK, Gustafson L, Brun A, Fischer P, Erkinjuntti T, Rosen W, et al. (1997). Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 49, 1096-1105.
19. Nagamachi S, Jinnouchi S, Nishii R, Ishida Y, Fujita S, Futami S, Kodama T, Tamura S, Kawai K (2004). Cerebral blood flow abnormalities induced by transient hypothyroidism after thyroidectomy - analysis by tc-99m-HMPAO and SPM96. Annals of Nuclear Medicine 18, 469-477.
20. Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, Morbelli S, Piccardo A, Vitali P, Rodriguez G (2005). Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease. Clinical Neurophysiology 116, 364-375.
21. Nobler MS, Roose SP, Prohovnik I, Moeller JR, Louie J, Van Heertum RL, Sackeim HA (2000). Regional cerebral blood flow in mood disorders, V: Effects of antidepressant medication in late-life depression. American Journal of Geriatric Psychiatry 8, 289-296.
22. Nobler MS, Sackeim HA, Prohovnik I, Moeller JR, Mukherjee S, Schnur DB, Prudic J, Devanand DP (1994). Regional cerebral blood flow in mood disorders, III. Treatment and clinical response. Archives of General Psychiatry 51, 884-897.
23. O'Brien MD, Harris PW (1968). Cerebral-cortex perfusion-rates in myxoedema. Lancet 1, 1170-1172.
24. Reinsel RA, Veselis RA, Dnistrian AM, Feshchenko VA, Beattie BJ, Duff MR (2000). Midazolam decreases cerebral blood flow in the left prefrontal cortex in a dose-dependent fashion. International Journal of Neuropsychopharmacology 3, 117-127.
25. Sampaolo S, Campos-Barros A, Mazziotti G, Carlomagno S, Sannino V, Amato G, Carella C, Di Iorio G (2005). Increased cerebrospinal fluid levels of 3,3′,5′-triiodothyronine in patients with Alzheimer's disease. Journal of Clinical Endocrinology and Metabolism 90, 198-202.
26. Scheinberg P, Stead Jr. EA, Brannon ES, Warren JV (1950). Correlative observations on cerebral metabolism and cardiac output in myxedema. Journal of Clinical Investigation 29, 1139-1146.
27. Schraml FV, Beason-Held LL, Fletcher DW, Brown BP (2006). Cerebral accumulation of Tc-99m ethyl cysteinate dimer (ECD) in severe, transient hypothyroidism. Journal of Cerebral Blood Flow and Metabolism 26, 321-329.
28. Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, Rafi-Tari S (2004). Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 22, 409-418.
29. Sensenbach W, Madison L, Eisenberg S, Ochs L (1954). The cerebral circulation and metabolism in hyperthyroidism and myxedema. Journal of Clinical Investigation 33, 1434-1440.
30. Sheline YI (2003). Neuroimaging studies of mood disorder effects on the brain. Biological Psychiatry 54, 338-352.
31. Smith DJ, Cavanagh JT (2005). The use of single photon emission computed tomography in depressive disorders. Nuclear Medicine Communications 26, 197-203.
32. Stover E, Fenton W, Rosenfeld A, Insel TR (2003). Depression and comorbid medical illness: the National Institute of Mental Health perspective. Biological Psychiatry 54, 184-186.
33. Thomas AJ, Kalaria RN, O'Brien JT (2004). Depression and vascular disease: what is the relationship? Journal of Affective Disorders 79, 81-95.